Best news conflated with bupropion generic wellbutrin subject.
Distribution of the products will commence immediately.
(Nasdaq: ELAB) announced today that it received final approval for Bupropion HCl, ER 200mg bupropion generic wellbutrin tablets, the generic equivalent of Wellbutrin SR(R)* 200mg tablets.
Bupropion HCl, ER is the generic equivalent for the brand Wellbutrin(R) SR(a), the antidepressant, which had sales of $1. 2 Billion in 2001. (b) Bupropion HCl, ER is one of four approvals Eon Labs has received in January 2002. Food and bupropion generic wellbutrin drug Administration (FDA) by Anchen Pharmaceuticals, Inc. , seeking marketing approval for 150mg and 300mg generic formulations of Wellbutrin XL(R) (once-daily bupropion). TORONTO -- Biovail Corporation (NYSE:BVF)(TSX:BVF) announced today the submission of a Citizen Petition with the Food and Drug Administration (FDA) to require rigorous bioequivalence testing for generic products that reference Wellbutrin XL(R) before they can be approved. All bioequivalence trials should calculate and evaluate parameters based on concentrations of the bupropion generic wellbutrin parent drug and active metabolites.
Fifteen of these filings were made under bupropion generic wellbutrin paragraph IV of the Hatch-Waxman Amendments. *Wellbutrin SR(R) is a registered trademark of GlaxoSmithKline and is not Bupropion generic wellbutrin affiliated with Eon Labs, Inc. Business Editors/Health/Medical Writers LAURELTON, N.
--(BUSINESS WIRE)--Jan. Although we believe that these statements are based upon reasonable assumptions, we cannot guarantee future results. The introduction of Bupropion HCI, ER 150mg tablets represents another first to market product for Eon Labs. (OTC: IPXL) reports that the U. In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances are forward-looking statements. Forward-looking statements speak only as of the date on which they are made, and the Company undertakes no obligation to update publicly or revise any forward-looking statement, whether as bupropion generic wellbutrin a result of new information, future developments or otherwise.Sales of Wellbutrin SR exceeded $530 million and sales of Zyban were nearly $110 million. Close to 90% of Teva's sales are in North America and Europe. Wellbutrin XL(R) tablets incorporate Biovail's Smartcoat(TM) technology and have a two-layer coating designed to release drug slowly in the body. Such statements are based on management's current beliefs and expectations and involve a number of known and unknown risks and uncertainties that could cause Teva's future results, performance or achievements to differ significantly from the results, performance or achievements expressed or implied by such forward-looking statements. Actavis Group, the international generic pharmaceuticals company, today announced that it has received two separate approvals from the U reproduced bupropion generic wellbutrin wherever. Bupropion generic wellbutrin yet imbalances in these brain chemicals are associated with depressed mood and other symptoms of depression. Safe Harbor statement under the Private Securities Litigation Reform Act of 1995: To the extent any statements made in this news release contain information that is not historical, these statements are forward-looking in nature and express the beliefs and expectations of management yet bupropion generic wellbutrin along with. "Safe Harbor" Statement Under the Private Securities Litigation Reform Act of 1995 To the extent any statements made in this release contain information that is not historical, these statements are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended dissected bupropion generic wellbutrin so. Biovail continues to develop a new and improved formulation of Wellbutrin XL(R) inherited disease bupropion generic wellbutrin.
Private Securities Litigation Reform Act of 1995: This release contains statements that are forward-looking in nature which express the beliefs and expectations of management. IMPAX markets its generic products through its Global Pharmaceuticals division and markets its branded products through the IMPAX Pharmaceuticals division. (NASDAQ: TEVA) announced today that it has commercially shipped Bupropion Hydrochloride Extended-Release Tablets, 300 mg, the generic version of Biovail Corporation's antidepressant Wellbutrin XL[R] Tablets, pursuant to an agreement with IMPAX Laboratories, Inc. Biovail has taken this step to protect patients against potentially serious risks (particularly seizures) which are currently disclosed in the approved Wellbutrin XL(R) labeling, and to ensure that generic versions of Wellbutrin XL(R) are as safe and effective as the innovator product. Bupropion generic wellbutrin if anchen was the first generic applicant to file an abbreviated new drug application (anda) containing a paragraph iv patent challenge on the patents related to the wellbutrin xl[r] tablet product and consequently was granted 180 days exclusivity, which it has now transferred to impax.